John Fesko Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 11 hours ago
John Fesko has an estimated net worth of at least $32.1 million*, as of Feb. 12, 2025. They own 156,044 shares of NTRA stock. They have sold 41,043 shares of NTRA stock since 2021, for an estimated $5.8 million.
John Fesko $NTRA SEC Form 4 Insider Trading
John Fesko has filed a total of 21 insider trades in $NTRA since 2021. Their most recent trade was a sale of 663 shares, made on Feb 06, 2025. Their largest trade was a sale of 21,175 shares, made on Jan 22, 2025. We estimate that they now own 156,044 shares of $NTRA, worth an estimated $26.3 million.
Insider Trading at $NTRA
There have been a total of 663 insider trades reported at $NTRA since 2021, with 375,220 shares purchased and 3.3 million shares sold. The most active insider traders in $NTRA stock have been Steven Leonard Chapman, Michael Burkes Brophy, and Daniel Rabinowitz. The most recent trade was a sale of 1,632 shares reported by Solomon Moshkevich (PRESIDENT, CLINICALDIAGNOSTICS), made on Feb 06, 2025.
History of Insider Stock Trades by John Fesko
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
NTRA
|
Sale | 663 | Feb 06, 2025 | Feb. 7, 2025, 10:35 p.m. |
|
NTRA
|
Sale | 2 | Jan 29, 2025 | Jan. 31, 2025, 10:35 p.m. |
|
NTRA
|
Sale | 3,115 | Jan 29, 2025 | Jan. 31, 2025, 10:35 p.m. |
|
NTRA
|
Sale | 913 | Jan 29, 2025 | Jan. 31, 2025, 10:35 p.m. |
|
NTRA
|
Sale | 53 | Jan 22, 2025 | Jan. 24, 2025, 10:45 p.m. |
|
NTRA
|
Sale | 21,175 | Jan 22, 2025 | Jan. 24, 2025, 10:45 p.m. |
|
NTRA
|
Sale | 668 | Dec 23, 2024 | Dec. 26, 2024, 10:05 p.m. |
|
NTRA
|
Sale | 1 | Dec 23, 2024 | Dec. 26, 2024, 10:05 p.m. |
|
NTRA
|
Sale | 929 | Oct 28, 2024 | Oct. 30, 2024, 9:35 p.m. |
|
NTRA
|
Sale | 199 | Oct 22, 2024 | Oct. 23, 2024, 9:35 p.m. |
|
NTRA
|
Sale | 342 | Oct 21, 2024 | Oct. 23, 2024, 9:35 p.m. |
|
NTRA
|
Sale | 3,956 | Aug 13, 2024 | Aug. 14, 2024, 9:05 p.m. |
|
NTRA
|
Sale | 929 | Jul 29, 2024 | July 31, 2024, 9:05 p.m. |
|
NTRA
|
Sale | 549 | Jul 22, 2024 | July 23, 2024, 9:05 p.m. |
|
NTRA
|
Sale | 1,438 | May 28, 2024 | May 30, 2024, 9:05 p.m. |
|
NTRA
|
Sale | 929 | Apr 29, 2024 | May 1, 2024, 9:05 p.m. |
|
NTRA
|
Sale | 522 | Apr 23, 2024 | April 23, 2024, 9:35 p.m. |
|
NTRA
|
Sale | 464 | Mar 28, 2024 | March 29, 2024, 9:35 p.m. |
|
NTRA
|
Sale | 15 | Mar 05, 2024 | March 7, 2024, 10:40 p.m. |
|
NTRA
|
Sale | 1,823 | Mar 05, 2024 | March 7, 2024, 10:40 p.m. |
|
NTRA
|
Sale | 2,358 | Jan 29, 2024 | Jan. 30, 2024, 9:57 p.m. |
$NTRA Executives and Stock Owners with Insider Trades
-
Steven Leonard Chapman, CEO AND PRESIDENT
-
Michael Burkes Brophy, CHIEF FINANCIAL OFFICER
-
Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER
-
Robert Alan Schueren, CHIEF OPERATING OFFICER
-
Matthew Rabinowitz, EXECUTIVE CHAIRMAN
-
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS
-
John Fesko, PRESIDENT, CHIEF BUS. OFFICER
-
Daniel Rabinowitz, CHIEF LEGAL OFFICER
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.